Press Release
Global Self-Monitoring Blood Glucose (SMBG) Devices Market is Estimated to Reach $20 Billion by 2024, Says Variant Market Research
 Published Date:  Sep 2017  Publish By: Variant Market Research

Global Self-Monitoring Blood Glucose (SMBG) Devices Market Report, published by Variant Market Research, forecast that the global market is expected to reach $20 Billion by 2024 from $12.3 Billion in 2016, growing at a CAGR of 6.2% from 2016 to 2024. By geography, Asia-Pacific and North America are expected to grow at a CAGR of 7.1% and 6.3%, respectively, during the forecast period.

"Self-Monitoring Blood Glucose (SMBG) Devices Market (By Type: Blood Glucose Meter, Blood Glucose Test Strips, Blood Glucose Lancet, And Others; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015 – 2024"

To browse the complete report, visit at: https://www.variantmarketresearch.com/report-categories/medical-devices/self-monitoring-blood-glucose-devices-market

Some of the factors driving the global self-monitoring blood glucose devices market are rising prevalence of diabetes, falling prices of devices, rising patient education, and availability of economic incentives. Though, increasing penetration of private label brands, and lack of awareness on benefits of regular blood glucose testing would hinder the growth of the market. New players with advanced technologies and improved marketing strategies would create several opportunities for the market players.

Type and geography are the major bifurcations considered in the global self-monitoring blood glucose (SMBG) devices market. By type, the segment is further categorized as blood glucose meter, blood glucose test strips, blood glucose lancet, and others. Among which, blood glucose test strip is likely to dominate with largest market share and fastest CAGR during the forecast period.

By geography, the market has been bifurcated into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America and Europe accounted the majority of the share in the market in 2016, with 39.8% and 34.7%, respectively. In terms of growth, Asia-Pacific is anticipated to dominate with fastest CAGR during the forecast period, driven by increasing commonness of diabetes, easy access to detection kits, and adoption of advanced technologies.

Major players operating in this market include F. Hoffmann-La Roche Ltd, B. Braun Melsungen AG, Medtronic Public Limited, Abbott Laboratories, Bayer AG, Life Scan Inc.(J&J), Arkray, Inc., Trividia Health Inc., Bionime Corporation, and Dexcom Inc., among others.

Contact Us:

John Dave,
Head - Sales 
Variant Market Research
649 Mission St, 5th Floor, San Francisco, CA 94105, United States.
Tel: +1-415-680-2785
Fax: +1-415-680-2786
Email: john.dave@variantmarketresearch.com 
Email: help@variantmarketresearch.com


GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Self-Monitoring Blood Glucose (SMBG) Devices Market by Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Blood Glucose Meter
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
    4.3 Blood Glucose Test Strips
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
    4.4 Blood Glucose Lancet
          4.4.1 Current Trend and Analysis
          4.4.2 Market Size and Forecast
    4.5 Other Types
          4.5.1 Current Trend and Analysis
          4.5.2 Market Size and Forecast
Chapter 5 Self-Monitoring Blood Glucose (SMBG) Devices Market by Geography: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 North America
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
          5.2.3 US
                   5.2.3.1 Market Size and Forecast
          5.2.4 Canada
                   5.2.4.1 Market Size and Forecast
          5.2.5 Mexico
                   5.2.5.1 Market Size and Forecast
    5.3 Europe
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
          5.3.3 Germany
                   5.3.3.1 Market Size and Forecast
          5.3.4 France
                   5.3.4.1 Market Size and Forecast
          5.3.5 United Kingdom
                   5.3.5.1 Market Size and Forecast
          5.3.6 Italy
                   5.3.6.1 Market Size and Forecast
          5.3.7 Russia
                   5.3.7.1 Market Size and Forecast
          5.3.8 Spain
                   5.3.8.1 Market Size and Forecast
          5.3.9 Others
                   5.3.9.1 Market Size and Forecast
    5.4 Asia-Pacific
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
          5.4.3 China
                   5.4.3.1 Market Size and Forecast
          5.4.4 India
                   5.4.4.1 Market Size and Forecast
          5.4.5 Japan
                   5.4.5.1 Market Size and Forecast
          5.4.6 Others
                   5.4.6.1 Market Size and Forecast
    5.5 RoW
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
          5.5.3 Middle East
                   5.5.3.1 Market Size and Forecast
          5.5.4 South America
                   5.5.4.1 Market Size and Forecast
          5.5.5 Africa
                   5.5.5.1 Market Size and Forecast
Chapter 6 Company Profiles
    6.1 F. Hoffmann-La Roche Ltd
    6.2 B. Braun Melsungen AG
    6.3 Medtronic Public Limited
    6.4 Abbott Laboratories
    6.5 Bayer AG
    6.6 Life Scan Inc.(J&J)
    6.7 Arkray, Inc.
    6.8 Trividia Health Inc.
    6.9 Bionime Corporation
    6.10 Dexcom Inc.

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha